LK

Lajos Kovacs

Director Director DIN 01297326
DIN 01297326 First appointment Mar 1997 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 1997
Shareholding value •••• Premium profile

About Lajos Kovacs

Data last updated:

Lajos Kovacs was a Director at Richter Themis Medicare (India) Private Limited (2004–2024) and Director at Themis Medicare Limited (1997–2022). The companies operate in Pharma.

DIN 01297326
Primary Designation Director
Industry Pharma
First Appointment 26 Mar 1997

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 20042004₹123 Cr (FY 2025)Active
Themis Medicare Limited L24110GJ1969PLC001590
Director26 Mar 19971969₹410 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Richter Themis Medicare (India) Private Limited
Themis Medicare Limited
Premium access

Shareholding and investment profile for Lajos Kovacs

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lajos Kovacs

Lajos Kovacs was first appointed on 26 Mar 1997 as Director at Themis Medicare Limited. The most recent appointment on record is 01 Nov 2004 at Richter Themis Medicare (India) Private Limited.

Lajos Kovacs held 2 earlier board appointments: Richter Themis Medicare (India) Private Limited (Director, 01 Nov 2004 to 18 Jun 2024); Themis Medicare Limited (Director, 26 Mar 1997 to 06 Sep 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available